Protagonist Therapeutics, Inc

Protagonist Therapeutics has reported zero cyber incidents and zero red-flag 8-K filings over the past 90 days, indicating baseline operational stability in our near-term monitoring window. However, a clean recent period does not eliminate dilution risk or longer-term financing pressures common in clinical-stage biotech—factors our 90-day snapshot cannot fully capture. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scores, maps financing history, and flags AI-detected signals of stress that may precede material events. The full $49 Report adds dilution trajectory, 12-month 8-K context, capital raise patterns, and AI risk signals.